PreprintCited by 13Computational Drug Discovery MethodsMachine Learning in BioinformaticsProtein Hydrolysis and Bioactive Peptides

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Exploration of DPP-IV inhibitory peptide design rules assisted by deep learning pipeline that identifies restriction enzyme cutting site

Open access

Preprint — published as 10.1021/acsomega.3c05571 · Paper page

Abstract

Mining of anti-diabetic dipeptidyl peptidase IV (DPP-IV) inhibitory peptides (DPP-IV-IPs) is currently a costly and laborious process. Due to the absence of rational peptide design rules, it relies on cumbersome screening of unknown enzyme hydrolysates. Here, we present an enhanced deep learning (DL) model called BERT-DPPIV, specifically designed to classify DPP-IV-IPs and exploring their design rules to discover potent candidates. The end-to-end model utilizes a fine-tuned bidirectional encoder representations (BERT) architecture to extract structural/functional information from input peptides and accurately identify DPP-IV-Ips from input peptides. Experimental results in benchmark dataset showed BERT-DPPIV yielded state-of-the-art accuracy of 0.894, surpassing the 0.797 obtained by sequence-feature model. Furthermore, we leverage the attention mechanism to uncover that our model could recognize restriction enzyme cutting site and specific residues that contribute to the inhibition of DPP-IV. Moreover, guided by BERT-DPPIV, proposed design rules of DPP-IV inhibitory tripeptides and pentapeptides were validated and they can be used to screen potent DPP-IV-IPs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2022.06.13.495896

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 31

  1. 10.1111/j.1742-1241.2006.01178.x · DOI
  2. 2019, Features of Dipeptidyl Peptidase IV (DPP-IV) Inhibitory Peptides from Dietary Proteins, J. Food Biochem, 43, e12451, 10.1111/jfbc.12451 · DOI
  3. 2021, Functional discovery and production technology for natural bioactive peptides, Chin. J. Biotechnol, 37, 2166
  4. 10.1210/er.2014-1035 · DOI
  5. 10.1016/j.bcp.2011.11.028 · DOI
  6. 2014, An in Silico Model to Predict the Potential of Dietary Proteins as Sources of Dipeptidyl Peptidase IV (DPP-IV) Inhibitory Peptides, Food Chem, 165, 489, 10.1016/j.foodchem.2014.05.090 · DOI
  7. 2014, In Silico Approaches to Predict the Potential of Milk Protein-Derived Peptides as Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, Peptides, 57, 43, 10.1016/j.peptides.2014.04.018 · DOI
  8. 2016, Structure Activity Relationship Modelling of Milk Protein-Derived Peptides with Dipeptidyl Peptidase IV (DPP-IV) Inhibitory Activity, Peptides, 79, 1, 10.1016/j.peptides.2016.03.005 · DOI
  9. 2018, Identification of Novel Dipeptidyl Peptidase IV (DPP-IV) Inhibitory Peptides in Camel Milk Protein Hydrolysates, Food Chem, 244, 340, 10.1016/j.foodchem.2017.10.033 · DOI
  10. 2016, Learnings from Quantitative Structure–Activity Relationship (QSAR) Studies with Respect to Food Protein-Derived Bioactive Peptides: A Review, RSC Adv, 6, 75400, 10.1039/C6RA12738J · DOI
  11. Advances in QSAR Modeling, 2017, Challenges and Advances in Computational Chemistry and Physics, 24, 3
  12. 10.1021/jm00390a003 · DOI
  13. 2020, Machine Intelligence in Peptide Therapeutics: A NextLgeneration Tool for Rapid Disease Screening, Med. Res. Rev, 40, 1276, 10.1002/med.21658 · DOI
  14. 2020, IDPPIV-SCM: A Sequence-Based Predictor for Identifying and Analyzing Dipeptidyl Peptidase IV (DPP-IV) Inhibitory Peptides Using a Scoring Card Method, J. Proteome Res, 19, 4125, 10.1021/acs.jproteome.0c00590 · DOI
  15. 2021, Identifying Dipeptidyl Peptidase-IV Inhibitory Peptides Based on Correlation Information of Physicochemical Properties, Int. J. Pept. Res. Ther, 27, 2651, 10.1007/s10989-021-10280-2 · DOI
  16. 2022, StackDPPIV: A Novel Computational Approach for Accurate Prediction of Dipeptidyl Peptidase IV (DPP-IV) Inhibitory Peptides, Methods, 204, 189, 10.1016/j.ymeth.2021.12.001 · DOI
  17. 2021, Machine Learning and Deep Learning, Electron. Mark., 31, 685, 10.1007/s12525-021-00475-2 · DOI · Paper page
  18. 10.1038/s41587-019-0036-z · DOI
  19. Youmans, M. ; Spainhour, C. ; Qiu, P . Long Short-Term Memory Recurrent Neural Networks for Antibacterial Peptide Identification. In 2017 IEEE International Conference on Bioinformatics and Biomedicine (BIBM); IEEE: Kansas City, MO, 2017; pp 498–502. https://doi.org/10.1109/BIBM.2017.8217697. · DOI
  20. 2020, Deep-AmPEP30: Improve Short Antimicrobial Peptides Prediction with Deep Learning, Mol. Ther. - Nucleic Acids, 20, 882, 10.1016/j.omtn.2020.05.006 · DOI
  21. 10.1186/s12859-019-3006-z · DOI
  22. 10.1093/bioinformatics/btx285 · DOI · Paper page
  23. Vaswani, A. ; Shazeer, N. ; Parmar, N. ; Uszkoreit, J. ; Jones, L. ; Gomez, A. N. ; Kaiser, Ł. ; Polosukin, I . Attention Is All You Need. In NIPS’17: Proceedings of the 31st International Conference on Neural Information Processing Systems; Long Beach, USA, 2017; pp 6000–6010. https://doi.org/10.5555/3295222.3295349. · DOI
  24. Vig, J . A Multiscale Visualization of Attention in the Transformer Model. In Proceedings of the 57th Annual Meeting of the Association for Computational Linguistics: System Demonstrations; Association for Computational Linguistics: Florence, Italy, 2019; pp 37–42. https://doi.org/10.18653/v1/P19-3007. · DOI · Paper page
  25. 10.1093/bib/bbab308 · DOI
  26. 2021, Strategic Preparations of DPP-IV Inhibitory Peptides from Val-Pro-Xaa and Ile-Pro-Xaa Peptide Mixtures, Int. J. Pept. Res. Ther, 27, 735, 10.1007/s10989-020-10122-7 · DOI
  27. 10.1002/jcc.25555 · DOI
  28. 2021, DNABERT: Pre-Trained Bidirectional Encoder Representations from Transformers Model for DNA-Language in Genome, Bioinformatics, 37, 2112, 10.1093/bioinformatics/btab083 · DOI · Paper page
  29. 2021, A Novel Antibacterial Peptide Recognition Algorithm Based on BERT, Brief. Bioinform, 22, bbab200, 10.1093/bib/bbab200 · DOI
  30. Devlin, J. ; Chang, M.-W. ; Lee, K. ; Toutanova, K. BERT: Pre-Training of Deep Bidirectional Transformers for Language Understanding. In Proceedings of the 2019 Conference of the North; Association for Computational Linguistics: Minneapolis, Minnesota, 2019; pp 4171–4186. https://doi.org/10.18653/v1/N19-1423. · DOI · Paper page
  31. Elnaggar, A. ; Heinzinger, M. ; Dallago, C. ; Rehawi, G. ; Wang, Y. ; Jones, L. ; Gibbs, T. ; Feher, T. ; Angerer, C. ; Steinegger, M. ; Bhowmik, D. ; Rost, B . ProtTrans: Towards Cracking the Language of Lifes Code Through Self-Supervised Deep Learning and High Performance Computing. IEEE Trans. Pattern Anal. Mach. Intell. 2021, 1–1. https://doi.org/10.1109/TPAMI.2021.3095381. · DOI

Metadata

Authors
Guan, C., Luo, J., Li, S., Tan, Z. L., Wang, Y., Chen, H., Yamamoto, N., Zhang, C., Lu, Y., Chen, J., & Xing, X.-H.
Affiliations
  • Tsinghua University (CN)
  • Harbin Institute of Technology (CN)
  • Tokyo Institute of Technology (JP)
  • Shenzhen Bay Laboratory (CN)
Corresponding author
  • Guan, Changge
  • Xing, Xin-Hui
Venue
ACS Omega
Publisher
openRxiv
Published
2022-06-16
Volume
8
Issue
42
Pages
39662-39672
ISSN
2470-1343 (ISSN-L)
OpenAlex
W4387608279
Cited by
13
References
1
Citations by year
2026: 5 · 2025: 2 · 2024: 6
FWCI
1.86
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • ACS Omega (publishedVersion, cc-by-nc-nd)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Natural Science Foundation of China (62102118)
  • Science, Technology and Innovation Commission of Shenzhen Municipality (KCXFZ2020 1221173207022)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Machine Learning in Bioinformatics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Protein Hydrolysis and Bioactive Peptides
Keywords
DPP-IV inhibitory peptides, dipeptidyl peptidase IV, BERT fine-tuning, attention mechanism, antidiabetic peptides, tripeptides, pentapeptide, peptide screening

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review